secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2026-08-04T11:09:38+00:00
Accession:  0001628280-26-052149
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q2 net loss $145.3M; revises FY2026 guidance down; divests Diabetes Health for $235M
--------------------------------------------------------------------------------

- Net revenue $740.3M (+12.7% YoY); organic growth 15.9%; net loss $145.3M vs net income $4.2M in prior year.
- Adjusted EBITDA $132.0M, down 3.2% YoY; includes $144.2M pre-tax goodwill impairment.
- FY2026 guidance revised: revenue $2.85-2.89B, Adj. EBITDA $490-520M, free cash flow $80-120M (from prior $680-730M Adj. EBITDA).
- Definitive agreement to sell Diabetes Health business for $235M cash; presented as discontinued operations.
- New capitated agreements: West Coast IDN at run-rate; Humana OneHome in FL/TX for ~478K members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828026052149/0001628280-26-052149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828026052149/ahco-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-052149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer